Inspire Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $532K | Buy |
2,431
+788
| +48% | +$172K | 0.06% | 277 |
|
|
2025
Q1 | $368K | Sell |
1,643
-284
| -15% | -$63.6K | 0.04% | 310 |
|
|
2024
Q4 | $631K | Buy |
1,927
+309
| +19% | +$101K | 0.08% | 186 |
|
|
2024
Q3 | $486K | Buy |
1,618
+237
| +17% | +$71.1K | 0.06% | 244 |
|
|
2024
Q2 | $455K | Buy |
1,381
+23
| +2% | +$7.58K | 0.06% | 228 |
|
|
2024
Q1 | $537K | Buy |
1,358
+238
| +21% | +$94.2K | 0.07% | 195 |
|
|
2023
Q4 | $394K | Sell |
1,120
-1,234
| -52% | -$435K | 0.06% | 222 |
|
|
2023
Q3 | $883K | Buy |
2,354
+1,457
| +162% | +$547K | 0.16% | 60 |
|
|
2023
Q2 | $343K | Buy |
897
+6
| +0.7% | +$2.3K | 0.07% | 142 |
|
|
2023
Q1 | $309K | Buy |
+891
| New | +$309K | 0.07% | 109 |
|
|
2021
Q1 | – | Sell |
-5
| Closed | -$1K | – | 740 |
|
|
2020
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 769 |
|